GB1269987A - Antacid composition - Google Patents

Antacid composition

Info

Publication number
GB1269987A
GB1269987A GB09070/69A GB1907069A GB1269987A GB 1269987 A GB1269987 A GB 1269987A GB 09070/69 A GB09070/69 A GB 09070/69A GB 1907069 A GB1907069 A GB 1907069A GB 1269987 A GB1269987 A GB 1269987A
Authority
GB
United Kingdom
Prior art keywords
antacid
composition
viscosity
gelation agent
gelation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB09070/69A
Other languages
English (en)
Inventor
Garland Richard Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1269987A publication Critical patent/GB1269987A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB09070/69A 1968-04-18 1969-04-14 Antacid composition Expired GB1269987A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72217668A 1968-04-18 1968-04-18
US78572768A 1968-12-20 1968-12-20

Publications (1)

Publication Number Publication Date
GB1269987A true GB1269987A (en) 1972-04-12

Family

ID=27110553

Family Applications (1)

Application Number Title Priority Date Filing Date
GB09070/69A Expired GB1269987A (en) 1968-04-18 1969-04-14 Antacid composition

Country Status (15)

Country Link
JP (1) JPS4621672B1 (enExample)
AU (1) AU438147B2 (enExample)
BE (1) BE731695A (enExample)
CA (1) CA959760A (enExample)
CH (1) CH536114A (enExample)
DE (1) DE1919802A1 (enExample)
DK (1) DK127269B (enExample)
ES (1) ES366173A1 (enExample)
FI (1) FI50831C (enExample)
FR (1) FR2007475A1 (enExample)
GB (1) GB1269987A (enExample)
IL (1) IL32020A (enExample)
NL (1) NL6906087A (enExample)
NO (1) NO129077B (enExample)
SE (1) SE388356B (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1374874A3 (en) * 2002-06-14 2004-01-07 McNEIL-PPC, INC. Liquid antacid compositions
WO2003066022A3 (en) * 2002-02-04 2004-01-22 Pharmacia Corp Stable pharmaceutical composition useful for treating gastrointestinal disorders
US9486436B2 (en) 2014-04-29 2016-11-08 The Procter & Gamble Company Method for making bismuth containing liquid pharmaceutical suspensions
US9486460B2 (en) 2014-04-29 2016-11-08 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
CN114732828A (zh) * 2022-04-27 2022-07-12 广西南宁百会药业集团有限公司 一种铝碳酸镁混悬液及其制备方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1401256A (en) * 1972-06-30 1975-07-16 Miles Lab Anticid tablet and preparation thereof
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
SE7905972L (sv) * 1979-07-09 1981-01-10 Haessle Ab Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand
EP0222834A4 (en) * 1985-04-18 1989-10-04 Borody Thomas J TREATMENT OF NON-ULCERATIVE DYSPEPSIA WITH BISMUTOUS SALTS.
IT1215332B (it) * 1987-01-12 1990-02-08 Crinos Industria Farmaco Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DE3812378A1 (de) * 1988-04-14 1989-10-26 Theo Mertens Mobile erntegutmahl- und -mischvorrichtung
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
DE4305919A1 (de) * 1993-02-26 1994-09-01 Ruediger Potthoff Transportsilo für Kunststoff-Granulat
AU2003211627A1 (en) * 2002-03-04 2003-09-16 Medrx Co., Ltd. Liquid matrix undergoing phase transfer in vivo and liquid oral preparations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621147A (enExample) *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003066022A3 (en) * 2002-02-04 2004-01-22 Pharmacia Corp Stable pharmaceutical composition useful for treating gastrointestinal disorders
US7135197B2 (en) 2002-02-04 2006-11-14 Pharmacia Corporation Stable pharmaceutical composition useful for treating gastrointestinal disorders
EP1374874A3 (en) * 2002-06-14 2004-01-07 McNEIL-PPC, INC. Liquid antacid compositions
AU2003204688B2 (en) * 2002-06-14 2008-04-10 Mcneil-Ppc, Inc. Liquid antacid compositions
US9486436B2 (en) 2014-04-29 2016-11-08 The Procter & Gamble Company Method for making bismuth containing liquid pharmaceutical suspensions
US9486460B2 (en) 2014-04-29 2016-11-08 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
US10034888B2 (en) 2014-04-29 2018-07-31 The Procter & Gamble Company Method for making bismuth containing liquid pharmaceutical suspensions
US10039835B2 (en) 2014-04-29 2018-08-07 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
US10532063B2 (en) 2014-04-29 2020-01-14 The Procter & Gamble Company Method for making bismuth containing liquid pharmaceutical suspensions
US10632200B2 (en) 2014-04-29 2020-04-28 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
CN114732828A (zh) * 2022-04-27 2022-07-12 广西南宁百会药业集团有限公司 一种铝碳酸镁混悬液及其制备方法

Also Published As

Publication number Publication date
DE1919802A1 (de) 1969-11-06
IL32020A (en) 1972-11-28
AU438147B2 (en) 1973-07-18
NO129077B (enExample) 1974-02-25
CA959760A (en) 1974-12-24
IL32020A0 (en) 1969-06-25
DK127269B (da) 1973-10-15
CH536114A (fr) 1973-04-30
AU5353969A (en) 1970-10-22
JPS4621672B1 (enExample) 1971-06-19
FR2007475A1 (enExample) 1970-01-09
FI50831B (enExample) 1976-04-30
BE731695A (enExample) 1969-10-20
NL6906087A (enExample) 1969-10-21
FI50831C (fi) 1976-08-10
ES366173A1 (es) 1971-04-01
SE388356B (sv) 1976-10-04

Similar Documents

Publication Publication Date Title
GB1269987A (en) Antacid composition
US3171752A (en) Contact lens treating solution
US2550622A (en) Ointment base and iodine ointment
KR900015741A (ko) 약제학적 조성물
AU697767B2 (en) Topically applicable pharmaceutical composition, process of manufacture, and use of the composition
ES439113A1 (es) Procedimiento para preparar productos farmaceuticos de pene-tracion a traves de la piel.
JPS614760A (ja) ヒアルロン酸塩−ポリ（エチレンオキサイド）組成物及びその化粧用製剤
KR950700072A (ko) 클린다마이신과 벤조일 페록사이드를 함유한 좌창 치료용 조성물(Composi-tions of clindamycin and benzoyl peroxide for acne treatment)
ES2004332T3 (es) Concentrados pirorretardantes y metodos para su produccion.
GB1340518A (en) Opthalmic solution
GB1257225A (enExample)
DE69401502D1 (de) Arzneizubereitung zum Herstellen eines stabilisierten Pulvers das eine Kombination aus Acetylsalicylsäure und Metoclopramid als Wirkstoff enthält
US2784100A (en) Calcium cyclamate tablet and process of making the same
US3326755A (en) Alginate containing antacid compositions
JPS5443212A (en) Shampoo composition
EP0308725A3 (en) Pharmaceutical composition for intrarectal administration of a calcitonin and unit dosage forms prepared therefrom
GB1512148A (en) Iodophor solution
US1495308A (en) James m
US2771395A (en) Aqueous alcoholic hair grooming preparation employing sodium carboxymethyl cellulose
GB1132576A (en) X-ray contrast media
IL94605A0 (en) Substituted aminoalkylbenzene derivatives,their manufacture and pharmaceutical compositions containing them
GB1354263A (en) Therapeutic composition
KR860003333A (ko) 나트륨 트리폴리포스 페이트의 제조방법
US915977A (en) Process of obtaining strong aqueous solutions of creosote.
Swafford et al. Some Pharmaceutical Uses of Carhopol 934